Burstein et al., 1992 - Google Patents
Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activitiesBurstein et al., 1992
View PDF- Document ID
- 3877946018561348220
- Author
- Burstein S
- Audette C
- Breuer A
- Devane W
- Colodner S
- Doyle S
- Mechoulam R
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
Two strategies for the design of therapeutically useful cannabinoids have been combined to produce compounds with greatly increased antiinflammatory activity and with a low potential for adverse side effects. Enantiomeric cannabinoids with a carboxylic acid group at position …
- 230000000694 effects 0 title abstract description 28
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2103/00—Systems containing at least three condensed rings
- C07C2103/02—Ortho- or ortho- and peri-condensed systems
- C07C2103/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2103/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2103/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulfur atoms in positions 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulfur atoms in positions 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, -CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Burstein et al. | Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities | |
US5338753A (en) | (3R,4R)-Δ6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesics | |
Singh et al. | Anticancer activity and toxicity profiles of 2-benzylidene indanone lead molecule | |
EP1299374B1 (en) | Novel non-psychotropic cannabinoids | |
US4876276A (en) | (3S-4S)-7-hydroxy-Δ6 -tetrahydrocannabinols | |
Nazimova et al. | Discovery of highly potent analgesic activity of isopulegol-derived (2 R, 4a R, 7 R, 8a R)-4, 7-dimethyl-2-(thiophen-2-yl) octahydro-2 H-chromen-4-ol | |
IL182272A (en) | Derivatives of tricyclic diterpene compounds | |
KR20060111494A (en) | Nitric oxide donating derivatives for the treatment of cardiovascular disorders | |
JPS6033834B2 (en) | Production method of hexahydrodibenzopyranones | |
JPS6011037B2 (en) | Method for producing aminodibenzo[b,d]pyrans | |
EP2501669B1 (en) | Arylated camphenes, processes for their preparation and uses thereof | |
US5321044A (en) | 15,16-seco-19-nor progestins | |
Murillo et al. | Antileishmanial activity and cytotoxicity of ent-beyerene diterpenoids | |
El-Desoky et al. | Isolation, synthesis, and structure–activity relationship study on daphnane and tigliane diterpenes as HIV latency-reversing agents | |
EP0154887B1 (en) | New 2,5-diaryl tetrahydrothiophenes and analogs thereof as paf-antagonists | |
Yang et al. | Bioactive terpenoids from Euonymus verrucosus var. pauciflorus showing NO inhibitory activities | |
Chantarasriwong et al. | Caged Garcinia xanthones: Synthetic studies and pharmacophore evaluation | |
Li et al. | Total synthesis of plagiochin G and derivatives as potential cancer chemopreventive agents | |
Wang et al. | Nitric oxide-donating genistein prodrug: design, synthesis, and bioactivity on MC3T3-E1 cells | |
JPS62209070A (en) | Neolignane derivative | |
KR100257183B1 (en) | Method for isolating pinusolide from biota orientalis, and paf-antagonist containing pinusolide as main component | |
Cheng | Five new sesquiterpenoids from the agarwood of Aquilaria sinensis | |
GB2292885A (en) | Method of treating hyperlipidemia | |
JPS5967264A (en) | Trienoic higher fatty acid pyridyl alcohol ester and its preparation | |
AU594677B2 (en) | Methods and compositions for inhibiting lipoxygenase |